Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition

Autor: Das, Nitin A., Carpenter, Andrea J., Belenchia, Anthony, Aroor, Annayya R., Noda, Makoto, Siebenlist, Ulrich, Chandrasekar, Bysani, DeMarco, Vincent G.
Zdroj: In Cellular Signalling April 2020 68
Databáze: ScienceDirect